載入...
Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori
Helicobacter pylori (H. pylori) is a life-threatening pathogen which causes chronic gastritis, gastric ulcers and even stomach cancer. Treatment normally involves bacterial eradication; however, this type of treatment only has a rate of effectiveness of <80%. Thus, it is a matter of some urgency...
Na minha lista:
| 發表在: | Int J Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4501646/ https://ncbi.nlm.nih.gov/pubmed/26080893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2015.2251 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|